Financial results - MEDOFARM S.R.L.

Financial Summary - Medofarm S.r.l.
Unique identification code: 7940730
Registration number: J17/1797/1995
Nace: 4773
Sales - Ron
336.825
Net Profit - Ron
8.799
Employees
5
Open Account
Company Medofarm S.r.l. with Fiscal Code 7940730 recorded a turnover of 2024 of 336.825, with a net profit of 8.799 and having an average number of employees of 5. The company operates in the field of Comerţ cu amănuntul al produselor farmaceutice having the NACE code 4773.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Medofarm S.r.l.

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR 178.730 183.924 203.813 209.449 206.540 207.478 216.072 270.006 282.098 336.825
Total Income - EUR 181.061 184.856 204.110 209.639 206.554 207.518 216.266 270.575 283.163 338.426
Total Expenses - EUR 167.551 175.783 192.212 206.925 200.406 191.879 204.678 252.586 258.540 320.991
Gross Profit/Loss - EUR 13.509 9.073 11.898 2.715 6.148 15.639 11.588 17.989 24.622 17.434
Net Profit/Loss - EUR 11.348 7.621 9.886 620 4.188 13.770 9.526 15.689 22.418 8.799
Employees 3 4 4 4 5 4 4 4 4 5
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 20.1%, from 282.098 euro in the year 2023, to 336.825 euro in 2024. The Net Profit decreased by -13.493 euro, from 22.418 euro in 2023, to 8.799 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Medofarm S.r.l.

Rating financiar

Financial Rating -
MEDOFARM S.R.L.

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Medofarm S.r.l.

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Medofarm S.r.l.

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Medofarm S.r.l.

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Medofarm S.r.l. - CUI 7940730

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets 14.437 18.871 18.549 16.422 14.441 12.771 11.282 10.106 8.870 9.664
Current Assets 53.991 44.373 63.936 68.176 63.988 64.213 73.668 85.634 110.193 112.277
Inventories 25.162 31.615 31.066 28.152 31.243 29.891 31.675 46.915 51.489 51.998
Receivables 21.400 4.415 26.157 28.361 23.014 29.593 36.302 32.649 30.530 41.226
Cash 7.429 8.343 6.713 11.664 9.731 4.729 5.691 6.070 28.174 19.053
Shareholders Funds 20.798 20.986 23.075 23.271 12.258 21.661 30.707 30.269 52.595 47.216
Social Capital 45 45 44 43 42 41 40 41 40 40
Debts 47.630 42.258 59.410 61.328 66.171 55.323 54.243 65.471 66.468 74.725
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "4773 - 4773"
CAEN Financial Year 4773
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 112.277 euro in 2024 which includes Inventories of 51.998 euro, Receivables of 41.226 euro and cash availability of 19.053 euro.
The company's Equity was valued at 47.216 euro, while total Liabilities amounted to 74.725 euro. Equity decreased by -5.085 euro, from 52.595 euro in 2023, to 47.216 in 2024.

Risk Reports Prices

Reviews - Medofarm S.r.l.

Comments - Medofarm S.r.l.

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.